Annual Operating Expenses
$18.18 B
+$1.66 B+10.05%
31 March 2024
Summary:
Takeda Pharmaceutical Company Limited annual total operating expenses is currently $18.18 billion, with the most recent change of +$1.66 billion (+10.05%) on 31 March 2024. During the last 3 years, it has risen by +$1.15 billion (+6.73%). TAK annual operating expenses is now at all-time high.TAK Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$3.42 B
-$779.15 M-18.55%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited quarterly total operating expenses is currently $3.42 billion, with the most recent change of -$779.15 million (-18.55%) on 01 September 2024. Over the past year, it has dropped by -$1.76 billion (-34.02%). TAK quarterly operating expenses is now -48.34% below its all-time high of $6.62 billion, reached on 31 March 2011.TAK Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.1% | -34.0% |
| 3 y3 years | +6.7% | -20.2% |
| 5 y5 years | +60.8% | -23.1% |
TAK Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +10.1% | -36.3% | at low |
| 5 y | 5 years | at high | +60.8% | -36.3% | at low |
| alltime | all time | at high | +531.2% | -48.3% | +478.9% |
Takeda Pharmaceutical Company Limited Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.42 B(-18.6%) |
| June 2024 | - | $4.20 B(+9.1%) |
| Mar 2024 | $18.18 B(+10.1%) | $3.85 B(-28.3%) |
| Dec 2023 | - | $5.37 B(+3.6%) |
| Sept 2023 | - | $5.18 B(+25.0%) |
| June 2023 | - | $4.15 B(+11.0%) |
| Mar 2023 | $16.52 B(-3.9%) | $3.74 B(-14.2%) |
| Dec 2022 | - | $4.35 B(+1.5%) |
| Sept 2022 | - | $4.29 B(+5.0%) |
| June 2022 | - | $4.08 B(-1.5%) |
| Mar 2022 | $17.18 B(+0.9%) | $4.14 B(-6.4%) |
| Dec 2021 | - | $4.43 B(+3.4%) |
| Sept 2021 | - | $4.28 B(+2.0%) |
| June 2021 | - | $4.20 B(-2.9%) |
| Mar 2021 | $17.03 B(-4.8%) | $4.32 B(+2.5%) |
| Dec 2020 | - | $4.22 B(-8.8%) |
| Sept 2020 | - | $4.63 B(+25.6%) |
| June 2020 | - | $3.68 B(+0.5%) |
| Mar 2020 | $17.90 B(+58.3%) | $3.67 B(-24.2%) |
| Dec 2019 | - | $4.84 B(+8.8%) |
| Sept 2019 | - | $4.45 B(-4.6%) |
| June 2019 | - | $4.66 B(-2.7%) |
| Mar 2019 | $11.30 B(+15.2%) | $4.79 B(+117.4%) |
| Dec 2018 | - | $2.20 B(-0.5%) |
| Sept 2018 | - | $2.22 B(+4.9%) |
| June 2018 | - | $2.11 B(-46.2%) |
| Mar 2018 | $9.82 B(-1.3%) | $3.92 B(+71.8%) |
| Dec 2017 | - | $2.28 B(-6.8%) |
| Sept 2017 | - | $2.45 B(+105.7%) |
| June 2017 | - | $1.19 B(-66.2%) |
| Mar 2017 | $9.94 B(+4.5%) | $3.53 B(+46.8%) |
| Dec 2016 | - | $2.40 B(-7.6%) |
| Sept 2016 | - | $2.60 B(+92.8%) |
| June 2016 | - | $1.35 B(-51.1%) |
| Mar 2016 | $9.51 B | $2.76 B(+16.8%) |
| Dec 2015 | - | $2.36 B(+10.8%) |
| Sept 2015 | - | $2.13 B(-6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $2.27 B(-57.1%) |
| Mar 2015 | $12.68 B(+19.5%) | $5.30 B(+127.2%) |
| Dec 2014 | - | $2.33 B(-6.1%) |
| Sept 2014 | - | $2.48 B(+10.6%) |
| June 2014 | - | $2.25 B(-28.2%) |
| Mar 2014 | $10.60 B(-14.8%) | $3.13 B(+20.5%) |
| Dec 2013 | - | $2.59 B(+4.7%) |
| Sept 2013 | - | $2.48 B(+4.0%) |
| June 2013 | - | $2.38 B(-32.8%) |
| Mar 2013 | $12.44 B(+21.1%) | $3.54 B(+20.1%) |
| Dec 2012 | - | $2.95 B(+0.9%) |
| Sept 2012 | - | $2.92 B(+0.8%) |
| June 2012 | - | $2.90 B(-9.3%) |
| Mar 2012 | $10.27 B(+20.4%) | $3.20 B(+9.6%) |
| Dec 2011 | - | $2.92 B(-17.3%) |
| Sept 2011 | - | $3.53 B(+398.5%) |
| June 2011 | - | $707.58 M(-89.3%) |
| Mar 2011 | $8.53 B(+4.1%) | $6.62 B(+731.1%) |
| Dec 2010 | - | $796.76 M(+10.3%) |
| Sept 2010 | - | $722.23 M(+7.0%) |
| June 2010 | - | $674.97 M(-88.9%) |
| Mar 2010 | $8.20 B(-13.5%) | $6.08 B(+640.7%) |
| Dec 2009 | - | $820.31 M(+8.4%) |
| Sept 2009 | - | $756.49 M(+13.6%) |
| June 2009 | - | $665.85 M(-89.0%) |
| Mar 2009 | $9.48 B(+60.5%) | $6.04 B(+921.9%) |
| Dec 2008 | - | $590.92 M(-26.6%) |
| Sept 2008 | - | $805.39 M |
| Mar 2008 | $5.91 B(+21.8%) | - |
| Mar 2007 | $4.85 B(+4.0%) | - |
| Mar 2006 | $4.66 B(+9.2%) | - |
| Mar 2005 | $4.27 B(+8.1%) | - |
| Mar 2004 | $3.95 B(+10.6%) | - |
| Mar 2003 | $3.57 B(+15.6%) | - |
| Mar 2002 | $3.09 B(-3.5%) | - |
| Mar 2001 | $3.20 B(+11.2%) | - |
| Mar 2000 | $2.88 B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total operating expenses?
- What is the all time high annual operating expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual operating expenses year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly operating expenses year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total operating expenses?
The current annual operating expenses of TAK is $18.18 B
What is the all time high annual operating expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total operating expenses is $18.18 B
What is Takeda Pharmaceutical Company Limited annual operating expenses year-on-year change?
Over the past year, TAK annual total operating expenses has changed by +$1.66 B (+10.05%)
What is Takeda Pharmaceutical Company Limited quarterly total operating expenses?
The current quarterly operating expenses of TAK is $3.42 B
What is the all time high quarterly operating expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total operating expenses is $6.62 B
What is Takeda Pharmaceutical Company Limited quarterly operating expenses year-on-year change?
Over the past year, TAK quarterly total operating expenses has changed by -$1.76 B (-34.02%)